Cargando…
Hypokalemia After Rituximab Administration in Steroid-Dependent Nephrotic Syndrome: A Case Report
The monoclonal antibody rituximab is a commonly used steroid sparing agent for steroid-dependent idiopathic nephrotic syndrome of childhood. With this brief report, we describe the first case of symptomatic hypokalemia after intravenous rituximab administration in a young woman. The sudden onset of...
Autores principales: | Guzzi, Francesco, Giovannini, Mattia, Errichiello, Carmela, Liccioli, Giulia, Mori, Francesca, Roperto, Rosa Maria, Romagnani, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311762/ https://www.ncbi.nlm.nih.gov/pubmed/32625098 http://dx.doi.org/10.3389/fphar.2020.00915 |
Ejemplares similares
-
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
por: Song, Yiyun, et al.
Publicado: (2023) -
Urinary Biomarkers for Diagnosis and Prediction of Acute Kidney Allograft Rejection: A Systematic Review
por: Guzzi, Francesco, et al.
Publicado: (2020) -
Population Pharmacokinetics of Rituximab in Pediatric Patients With Frequent-Relapsing or Steroid-Dependent Nephrotic Syndrome
por: Chen, Yewei, et al.
Publicado: (2021) -
Look Alike, Sound Alike: Phenocopies in Steroid-Resistant Nephrotic Syndrome
por: Becherucci, Francesca, et al.
Publicado: (2020) -
Necrotizing Fasciitis: A Side Effect of Rituximab Administration in Steroid-Dependent Nephrotic Syndrome
por: Safdar, Osama Yousif, et al.
Publicado: (2022)